Actelion presents outstanding 2015 results - Company transformation progressing well (Actelion Ltd)

(Source: Actelion Ltd) ALLSCHWIL/BASEL, SWITZERLAND - 09 February 2016- Actelion Ltd (SIX: ATLN) today announced its results for the full year 2015. OPERATING HIGHLIGHTS Opsumit - Strong, sustained launch trajectory across markets Uptravi - Approved and launched in the US Uptravi - EU filing resulted in positive CHMP opinion Pipeline - Advancing late-stage assets Pipeline - Significant progress in discovery and early-stage development FINANCIAL HIGHLIGHTS Product sales cross CHF 2 billion - driven by excellent Opsumit sales (CHF 516 m) Core earnings of CHF 814 million, up 14% at CER (up 25% ex US rebate reversals) Core EPS of CHF 6.16, an increase of 15% at CER Almost CHF 1 billion returned...